There's a new frontier in treating autoimmune diseases. Today's treatments tamp down the friendly fire but don't fix what's ...
It's one of medicine's biggest mysteries — why sometimes our immune system attacks our own bodies. Autoimmune diseases affect ...
Fenebrutinib met primary goals in two late-stage trials for the treatment of two different forms of multiple sclerosis.
About 1 million people in the U.S. live with multiple sclerosis, a chronic autoimmune disease that inflames the nervous ...
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune condition in which the body's ...
Early intervention and effective therapies are transforming multiple sclerosis management, enhancing patient outcomes, and delaying disability progression.
About 1 million people in the U.S. live with multiple sclerosis, a chronic autoimmune disease that inflames the nervous ...